The director's large, self-funded purchases suggest strong conviction in the company's prospects, potentially signaling undervaluation or upcoming positive developments. Traders should monitor for follow-on buying and any near-term corporate updates.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 6 $24.22entry
- T+1 · 8mo ago +4.29%α +3.45% · $25.26
- T+5 · 8mo ago +12.01%α +13.54% · $27.13
- T+20 · 8mo ago −1.82%α +0.23% · $23.78
- T+60 · 6mo ago +15.03%α +2.25% · $27.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Over the past week, two executives at PROCEPT BioRobotics sold shares totaling approximately $323,000, while a director, Desai Antal Rohit, made significant open-market purchases totaling over $3.5 million. The buying activity by the director substantially outweighs the selling by executives in both volume and value.
Key Financial Metrics
Key Facts
- Director Desai Antal Rohit purchased 150,135 shares over two days for a total of $3,535,213.23 in open-market transactions.
- EVP & CFO Kevin Waters sold 6,721 shares for $159,300.47; EVP Nouri Alaleh sold a total of 10,990 shares for $242,673.76 across two trades.
- Total insider buying in the cluster: $3.54M; total selling: $322,624.23.
- Net insider activity is strongly positive, with buying representing ~92% of total transaction value.
- All transactions were open-market (P/S codes), not derivative or tax-related events.
Financial Impact
$3.54 million in insider buying versus $323,000 in selling over 7 days
Risk Factors
- Selling by CFO and Chief Legal Officer may raise questions, though amounts are relatively small and could be for personal financial planning.
- Single-director concentration: the bullish signal hinges heavily on one buyer.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (5 trades, 7d window) | cluster-PRCT-1773345787285 |
Track record
16 reports on PRCT
3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +22.73% at T+60 after the Feb 26, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $20.62 Now $23.54 +14.16% settles Feb 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $20.27 Now $23.54 +16.13% settles Feb 3
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $19.20 Now $23.54 +22.60% settles Jan 28
- Oct 2, 20266w ago 8-K Neutral 2/10 Entry $17.82 Now $23.54 +32.10% settles Dec 30
- Sep 24, 20267w ago 8-K Neutral 3/10 Entry $17.20 Now $23.54 +36.86% settles Dec 21
- Aug 10, 202614w ago Insider Buy Bullish 5/10 Entry $21.71 to $19.98 Now $23.54 +8.43% ▼ −7.99% −6.09% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
- Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
- Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
- Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers